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Introduction
The ability of cancer cells to disseminate from primary   tumors 
(and metastases) gives rise to a growing tumor burden that is 
distributed in multiple sites in the body, resulting in death for 
many cancer patients. Understanding the steps at the cellular 
level that are used by cancer cells during invasion and metasta-
sis can form the basis for new diagnostic, prognostic, and thera-
peutic approaches that allow control of cancer malignancy.
Microarray-based expression analysis of whole tumors 
has been used to identify genes involved in metastasis and 
  patterns of gene expression that would give an indication of 
the likelihood of metastasis of breast tumors (van’t Veer 
et al., 2002; Ramaswamy et al., 2003). These studies have suc-
cessfully identifi  ed patterns of gene expression that correlate 
with metastasis; however, these patterns have not been informa-
tive with regard to the mechanisms contributing to metastasis 
because the expression patterns of all cells of the tumor are av-
eraged (Wang et al., 2005). We have developed an in vivo inva-
sion assay that provides an opportunity to collect primary tumor 
cells that are actively in the process of invasion. The in vivo in-
vasion assay has been combined with array-based gene expres-
sion analyses to investigate the gene expression patterns of 
carcinoma cells in primary mammary tumors during invasion 
(Wang et al., 2004). The expression of genes involved in cell 
  division, survival, and motility were most dramatically changed 
in invasive cells, indicating a population that is neither dividing 
nor apoptotic but intensely motile (Goswami et al., 2004; Wang 
et al., 2004). In particular, the genes coding for the three end 
stage effectors (Arp2/3 complex, capping protein, and cofi  lin) 
of the minimum motility machine that regulates actin polymer-
ization at the leading edge and, therefore, the motility and che-
motaxis of carcinoma cells were up-regulated. Interestingly, in 
the cofi  lin pathway, LIM kinase 1 (LIMK1) and cofi  lin were 
coordinately up-regulated in invasive cells (Wang et al., 2004). 
Chemotaxis to EGF is an important determinant in the haema-
togenous metastasis of mammary tumors (Wyckoff et al., 2004), 
and cofi  lin is required for chemotaxis to EGF (Mouneimne 
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nderstanding the mechanisms controlling can-
cer      cell invasion and metastasis constitutes a 
fundamental step in setting new strategies for di-
agnosis, prognosis, and therapy of metastatic   cancers. 
LIM kinase1 (LIMK1) is a member of a novel class 
of  serine–threonine protein kinases. Coﬁ   lin, a LIMK1 
substrate, is essential for the regulation of actin poly-
merization and depolymerization during cell migration. 
Previous studies have made opposite conclusions as 
to the role of LIMK1 in tumor cell motility and meta-
stasis, claiming either an increase or decrease in cell 
motility and metastasis as a result of LIMK1 over ex-
pression (Zebda, N., O. Bernard, M. Bailly, S. Welti, 
D.S. Lawrence, and J.S. Condeelis. 2000. J. Cell Biol. 
151:1119–1128; Davila, M., A.R. Frost, W.E. Grizzle, 
and R. Chakrabarti. 2003. J. Biol. Chem. 278:36868–
36875; Yoshioka, K., V. Foletta, O. Bernard, and 
K. Itoh. 2003. Proc. Natl. Acad. Sci. USA. 100:7247–
7252; Nishita, M., C. Tomizawa, M. Yamamoto, 
Y. Horita, K. Ohashi, and K. Mizuno. 2005. J. Cell Biol. 
171:349–359). We resolve this paradox by showing 
that the effects of LIMK1 expression on migration, in-
travasation, and metastasis of cancer cells can be most 
simply explained by its regulation of the output of the 
coﬁ  lin pathway. LIMK1-mediated decreases or increases 
in the activity of the coﬁ  lin pathway are shown to cause 
proportional   decreases or increases in motility, intrava-
sation, and metastasis of tumor cells.
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et al., 2004). Thus, it is essential to understand how the LIMK–
cofi  lin pathway contributes to metastasis.
LIMK1 is a member of a novel class of serine–threonine 
protein kinases that contain two tandem LIM domains at the 
amino terminus, a PDZ domain in the central region, and a pro-
tein kinase domain at the carboxy terminus (Okano et al., 1995). 
Cofi  lin is the only known physiological substrate of LIMK1. 
LIMK1 phosphorylates cofi  lin, which inactivates it. This in-
hibits cofi  lin’s actin-severing and depolymerization activities 
(Arber et al., 1998; Yang et al., 1998; Zebda et al., 2000).
Cofi  lin activity is required for tumor cell motility and 
  invasion. Local activation of cofi  lin by uncaging induces lamel-
lipod formation and sets the direction of cell motility (Ghosh 
et al., 2004). Inhibition of cofi  lin activity in carcinoma cells 
with either siRNA (Hotulainen et al., 2005) or the expression of 
constitutively active LIMK domain (Zebda et al., 2000) inhibits 
cell motility. The suppression of cofi  lin expression with siRNA 
reduces the invasion of carcinoma cells by reducing the assem-
bly and stability of invadopodia (Yamaguchi et al., 2005a). The 
overexpression of cofi  lin increases the velocity of cell migration 
in Dictyostelium (Aizawa et al., 1996) and in human glioblas-
toma cells (Yap et al., 2005). The spontaneous overexpression 
of cofi  lin has been detected in the invasive subpopulation of 
  tumor cells in mammary tumors (Wang et al., 2004). Cofi  lin 
is overexpressed in the highly invasive C6 rat glioblastoma cell 
line (Gunnersen et al., 2000), and the amount of phosphory-
lated, inactive cofi  lin is decreased in cell lines derived from 
T lymphoma (Jurkat) and carcinomas from the cervix (HeLa), 
colon (KM12), liver (HepG2), and kidney (COS1; Nebl et al., 
1996). These results suggest that cofi  lin activity enhances, but 
LIMK activity inhibits, cell motility and metastasis.
In previous studies, LIMK1 has been shown to affect cell 
motility and invasion, but there is confusion about whether 
LIMK increases or decreases invasion. The expression of a con-
stitutively active LIMK1 that increases the amount of phospho-
cofi  lin in vivo inhibits actin polymerization and motility in 
response to EGF in mammary carcinoma cells (Zebda et al., 
2000). In addition, the overexpression of LIMK suppresses mo-
tility in neuroblastoma, and dominant-negative LIMK increases it 
(Nishita et al., 2005). However, the overexpression of LIMK1 
in prostate epithelial cells increased their invasiveness in vitro 
(Davila et al., 2003) and the formation of osteolytic lesions in 
nude mice (Yoshioka et al., 2003). Furthermore, a reduction in 
LIMK1 expression in metastatic prostate cell lines decreased 
their ability to invade matrigel in vitro (Davila et al., 2003). 
Clearly, these studies do not agree as to the consequences of 
LIMK1 expression on invasion. Therefore, it is likely that 
LIMK1 expression alone is not involved directly in determining 
the motility and invasion status of carcinoma cells.
Cofi  lin, the substrate of LIMK1, is directly responsible for 
severing actin fi  laments and regulating actin polymerization 
and depolymerization during cell migration (Desmarais et al., 
2005). It is required for cell motility because reduced cofi  lin 
  expression levels correlate with the inhibition of locomotion 
(Hotulainen et al., 2005), whereas increased expression levels 
correlate with enhanced motility (Yap et al., 2005). Hence, 
 cofi  lin is arguably the key effector in the cofi  lin pathway that 
determines cell migration and invasion, whereas LIMK1 may 
only serve to modify the level of cofi  lin activity. We propose 
that the output of the cofi  lin pathway—the generation of barbed 
ends during the fi  rst transient after EGF stimulation by cofi  lin, 
which is required for chemotaxis to EGF (Mouneimne et al., 
2004)—is the key determinant of whether a carcinoma cell will 
be more or less motile and invasive. This hypothesis is based on 
results demonstrating that the activation of cofi  lin is suffi  cient 
to stimulate cell protrusion and motility and determine the 
  direction of locomotion (Ghosh et al., 2004), that cofi  lin activity 
is required for the chemotaxis of carcinoma cells to EGF (Ghosh 
et al., 2004; Mouneimne et al., 2004), and that invasive cells 
isolated from mammary tumors overexpress cofi   lin and its 
  upstream regulatory proteins (Wang et al., 2004). Therefore, if 
the activity status of the cofi  lin pathway can be altered by vary-
ing the expression of LIMK1, perhaps the metastatic potential 
of tumor cells might be related to LIMK1 expression.
In this study, we test this hypothesis by varying the 
  expression of LIMK1 and its dominant-negative kinase domain 
in the rat MTLn3 carcinoma cell line to examine the effects on 
the activity of the cofi  lin pathway and invasion and metastasis 
of primary mammary tumors grown from these cells. The full-
length LIMK1 and dominant-negative kinase domain were intro-
duced into MTLn3 cells, and stable cell lines were obtained. The 
output of the cofi  lin pathway (barbed end production in   response 
to EGF) was then measured and correlated with invasion and 
metastasis. Although other research groups have suggested that 
LIMK1 may play important roles in regulating breast tumor 
growth independently of cofi  lin (Davila et al., 2003; Roovers 
et al., 2003) and that overexpression of LIMK1 causes increased 
invasion directly (Yoshioka et al., 2003), our results indicate that 
the effects of LIMK1 on invasion, intravasation, and metastasis 
of cancer cells can be explained most simply by LIMK1’s regu-
lation of cofi  lin activity and cofi  lin-dependent cell motility.
Results
We have used a model of breast cancer that allows the direct 
  examination of the chemotaxis and invasion of individual carci-
noma cells in live metastatic primary tumors (Wang et al., 2004; 
Wyckoff et al., 2004). The metastatic tumor cell line used to cre-
ate these model tumors is the MTLn3 cell line. The invasive cells 
isolated from rat mammary tumors overexpress cofi  lin and its 
  upstream regulatory proteins in a pattern suggesting increased ac-
tivation of the cofi  lin pathway (Wang et al., 2004). Therefore, we 
propose that the cofi  lin pathway is one of the key determinants of 
whether a carcinoma cell will be more or less invasive and meta-
static. To test this hypothesis, we assessed the EGF-  induced early 
barbed end transient in invasive cells, which are cells that were 
collected by means of the in vivo invasion assay using micro-
needles from the primary tumor (Wyckoff et al., 2004). The level 
of barbed ends in tumor cells after 1 min of EGF stimulation has 
been shown previously to depend on the output of the cofi  lin 
pathway (Mouneimne et al., 2004). Therefore, the number of 
barbed ends in invasive tumor cells was compared with that in 
FACS-sorted tumor cells from the primary tumor, a population 
composed primarily of noninvasive cells (Wang et al., 2004). COFILIN REGULATES CANCER CELL INVASION • WANG ET AL. 397
The results show that the EGF-  induced cofi  lin-dependent early 
transient of barbed ends is increased in the invasive tumor cell 
population, indicating that the cofi  lin pathway regulating the early 
transient has increased activity (Fig. 1, A and B). 
To further test the hypothesis that the output of the cofi  lin 
pathway (the generation of barbed ends during the fi  rst transient 
of actin polymerization after EGF stimulation by cofi  lin) is 
the key determinant of whether a carcinoma cell will be more 
or less invasive and metastatic, four LIMK1 constructs were 
transfected separately into the parental MTLn3 cells. Stable 
transfectants were obtained for the full-length GFP-LIMK1 and 
dominant-negative GFP-KS (Fig. 2 A), which grew normally 
compared with control cells (MTLn3 cells transfected with 
pGreenLantern-1 vector). However, no stable cell lines were 
  obtained from GFP-FS (inactive GFP-tagged LIMK1 Short), 
which is consistent with an involvement of LIMK1 in regulating 
cell cycle dynamics independently of cofi  lin phosphorylation 
(Roovers et al., 2003). In addition, no stable cell lines were ob-
tained with GFP-K (constitutively active GFP-tagged kinase 
domain of LIMK1), which is consistent with (1) the ability of 
the constitutively active LIMK domain to completely inhibit co-
fi  lin activity measured as cofi  lin-mediated barbed end formation 
and protrusion (Zebda et al., 2000) and (2) the requirement of 
cofi  lin activity for cell viability (Gunsalus et al., 1995). Western 
blot analysis (Fig. 2 B) confi  rmed the expression of GFP-LIMK1 
and GFP-KS at approximately two to four times the levels of the 
endogenous LIMK1. These cell lines will hereafter be called 
GFP (GFP-expressing control), F (full-length LIMK-expressing 
cells), and KS (LIMK dead truncated). Although the total cofi  lin 
levels remained unchanged in all of the transfectants (Fig. 2 B), 
the phosphorylation of cofi  lin was greatly increased in F cells, 
decreased in KS cells, and unchanged in GFP cells (Fig. 2 B).
The early barbed end transient involved 
in chemotactic sensing is suppressed 
in F cells and enhanced in KS cells
To study the effects of LIMK expression on the EGF-induced 
free barbed end production, we examined the levels of free 
barbed ends in GFP, F, and KS cells at 1 min after EGF 
  stimulation. This time corresponds to the cofi  lin-dependent 
early barbed end transient in MTLn3 cells that is required for 
chemotaxis (Mouneimne et al., 2004). Overexpression of the 
full-length LIMK (F) in MTLn3 suppressed the early transient, 
whereas expression of the kinase-dead LIMK1 kinase domain 
(KS) induced a signifi  cant increase (P < 0.05) in the levels of 
barbed ends during the early transient (Fig. 3).  In addition, rest-
ing unstimulated KS cells (Fig. 3 B, 0 min) showed a signifi  cant 
elevation of free barbed ends as compared with F and GFP cells 
(P < 0.05). Knockdown of the exogenously expressed LIMK 
(F) and KS domain using siRNA that targets GFP (F and KS are 
GFP tagged) returned phospho-cofi  lin levels for both F (from 
66 ± 6% in F to 17.3 ± 0.9% after siRNA knockdown) and KS 
(from 11.0 ± 1.7% in KS to 19.6 ± 1.8% after siRNA knock-
down) to that of control GFP cells (18.0 ± 1.5%) and rescued 
the barbed ends to control levels (Fig. 3 B). GFP knockdown in 
the cells expressing GFP alone did not have any effect on EGF-
induced barbed ends (Fig. 3 B).
These results are consistent with the elevated phospho-
 cofi  lin levels seen in F cells and the decreased phospho-cofi  lin 
observed in KS cells (Fig. 2 B) because the phosphorylation of 
cofi  lin inhibits its severing activity, which is responsible for the 
early transient of barbed ends at 1 min after EGF stimulation 
(Mouneimne et al., 2004; Desmarais et al., 2005).
EGF-induced membrane protrusion 
and locomotion is inhibited 
in F but not KS cells
Chemotaxis toward EGF is a key step in the invasion 
and   intravasation of carcinoma cells in the primary tumor in 
vivo (Wyckoff et al., 2004), and these behaviors involve the 
Figure 1.  EGF-induced and coﬁ  lin-dependent early transient of barbed 
ends is increased in invasive tumor cells. (A) F-actin staining in control resi-
dent tumor cells isolated from the primary tumor by FACS sorting (primary 
tumor cells) compared with invasive tumor cells isolated from the primary 
tumor using the in vivo invasion assay. Cells are shown 1 min after EGF 
stimulation. Insets show the barbed end staining for the cropped areas. 
Bar, 10 μm. (B) Quantiﬁ  cation of the barbed end staining at 1 min after 
EGF stimulation. Error bars represent SEM from at least 15 cells collected 
in three independent experiments.JCB • VOLUME 173 • NUMBER 3 • 2006  398
 protrusion of lamellipods and invadopods (Mouneimne et al., 
2004;   Yamaguchi et al., 2005a). To determine the effects of 
LIMK-dependent cofi  lin phosphorylation on membrane pro-
trusion, EGF-stimulated GFP, F, and KS cells were examined 
for membrane protrusion activity and motility. The EGF-
  induced membrane protrusion was dramatically inhibited in 
F but not KS cells (Fig. 4 A, i and ii). Knockdown of F with 
siRNA   directed to GFP rescued the inhibition of protrusion 
such that F cells transfected with GFP-directed siRNA pro-
truded identically to control cells (Fig. 4 A, i). Interestingly, 
when wild-type cofi  lin was stably overexpressed in F cells 
(Fig. 4 B, F + CF), which overexpress LIMK, the inhibition of 
Figure 2.  Expression of LIMK constructs alters the 
phosphorylation of coﬁ   lin in vivo. (A) The con-
structs that were used to generate stable expres-
sion in F (LIMK overexpressers) and in KS (LIMK 
dead domain) cells. (B, left) Western blot showing 
the expression levels of the different LIMK1 con-
structs, coﬁ  lin,  and  β-actin in the different cell 
lines. (right) IEF gel showing the ratio of phospho-
coﬁ   lin to coﬁ   lin in the three different cell lines. 
  Coﬁ   lin phosphorylation was either unchanged 
(GFP), elevated (F), or suppressed (KS) in the three 
cell lines. The level of expression of total coﬁ  lin 
(both phospho-coﬁ  lin and nonphospho-coﬁ  lin) was 
unchanged between GFP, F, and KS cells. Error 
bars represent SEM.
Figure 3.  LIMK overexpression (F) suppresses the early barbed end transient, whereas inactive kinase domain (KS) increases the barbed end output of the 
coﬁ  lin pathway. (A) Representative images of GFP, F, and KS cells before and 1 min after EGF stimulation show that the barbed end staining at the leading 
edge is elevated in KS and suppressed in F cells. Bar, 10 μm. (B) The relative number of barbed ends (arbitrary units of ﬂ  uorescence intensity) at the leading 
edge (between 0 and 0.22 μm inside the cell edge) in GFP, GFP RNAi, F, F RNAi, KS, and KS RNAi cells at 0 and 1 min after EGF stimulation (black bars 
represent 0 min, and gray bars represent 1 min after EGF stimulation) showing that barbed end staining at the leading edge is elevated in KS and sup-
pressed in F cells, whereas siRNA suppression of F and KS expression returns barbed ends to control levels seen in GFP cells. Error bars represent SEM of 
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protrusion was also rescued, indicating that the elevation of 
cofi  lin expression is suffi  cient to restore protrusion in cells 
overexpressing LIMK (Fig. 4 A, iii). This demonstrates that the 
effect of F and KS overexpression on barbed ends and protru-
sion is caused by the direct perturbation of the cofi  lin pathway 
and is mediated by cofi  lin.
Next, we determined the effects of LIMK-dependent 
 cofi  lin phosphorylation on random cell motility. Under normal 
growth conditions, the velocity of F cells was signifi  cantly 
slower than that of GFP cells (P < 0.05), whereas the velocity 
of KS cells was elevated compared with control cells (P < 
0.01; Fig. 4 C).
Chemotaxis, invasion, intravasation, 
and metastasis depend on coﬁ  lin activity
During mammary tumor progression, tumors fi  ll with collagen-
rich extracellular matrix. Tumor cells are induced by macro-
phages to migrate on collagen fi  bers to blood vessels, where 
they intravasate (Condeelis and Segall, 2003; Wyckoff et al., 
2004). We used an in vitro invasion assay that reconstitutes 
the macrophage-induced invasion of collagen by tumor cells 
  (Goswami et al., 2005) to examine the invasive properties of 
GFP, F, and KS cells. When cultured alone, <5% of the GFP, F, 
and KS cells invade the collagen gel, whereas in the presence 
of BAC1.2F5 macrophages, >20% of the GFP and KS cells 
  invade the collagen, and F cells showed signifi  cantly reduced 
invasion (13%; Fig. 5 A). 
To investigate the chemotactic and invasive properties of 
tumor cells in tumors derived from the GFP, F, and KS cells, the 
ability of the carcinoma cells to chemotax and invade in the 
in vivo invasion assay was measured (Wang et al., 2004; 
Wyckoff et al., 2004). Although the chemotaxis of GFP and KS 
was similar to each other and was unchanged from wild-type 
cells in primary tumors, tumors generated from F cells had inva-
sion scores that were signifi  cantly reduced, indicating a red-
uction in chemotaxis and invasion in vivo. However, when 
Figure 4.  LIMK but not KS overexpression inhibits EGF-induced membrane protrusion and locomotion in a coﬁ  lin-dependent manner. (A) The average fold 
increase in membrane protrusion (area standardized over 0-s values) versus time after EGF addition in seconds shows that (i) F cells are dramatically sup-
pressed in their ability to protrude lamellipods in response to EGF, whereas GFP-directed RNAi transfection rescues the observed phenotype to normal; 
(ii) KS has no effect on protrusion; and (iii) overexpression of coﬁ  lin in the F cells also rescues the defect in protrusion as a result of F expression. Y axes 
are normalized axes where 1.0 = no activity. (B) When wild-type coﬁ  lin was stably overexpressed in F cells, the level of total coﬁ  lin (both phospho-coﬁ  lin 
and nonphospho-coﬁ  lin) was increased to 2.5 times the level seen in the G and F cells, as determined by Western blotting. The proportional phosphoryla-
tion of coﬁ  lin was greatly increased in F cells (66%) and dropped to 34% in the F + CF cells. (C) Instantaneous velocity of GFP, F, and KS cells as assessed 
by DIAS analysis of 1-h time-lapse videos of cells maintained in serum-supplied media (constitutive motility) demonstrates a lower velocity in F cells and an 
increased velocity in KS cells. Error bars represent SEM of  30 cells. *, P < 0.05; **, P < 0.01.JCB • VOLUME 173 • NUMBER 3 • 2006  400
wild-type cofi   lin was stably overexpressed in F cells, inva-
sion was rescued, indicating that the decrease in invasion in 
F cells was caused by a decrease in the activity of the cofi  lin 
pathway (Fig. 5 B).
The amount of intravasation and metastasis of mammary 
tumors derived from GFP, F, and KS cell lines was character-
ized by measuring the number of viable tumor cells present in 
the circulating blood (Fig. 6 A) and the number of spontane-
ously occurring lung metastatic tumors (Fig. 6 B). The results 
indicate that F tumors have reduced intravasation (approxi-
mately threefold) and metastasis (twofold), whereas KS 
tumors have signifi  cantly enhanced intravasation and metastatic 
activity when compared with GFP tumors.
The survival of animals with F and KS 
tumors is different
The consequence of increased metastatic spread of breast tu-
mors is decreased survival of the host. Therefore, we measured 
the survival of animals with mammary tumors derived from 
GFP, F, and KS cells. Fig. 7 A shows the survival curves of the 
populations of tumor-bearing animals. Animals with F tumors 
in which LIMK1 is overexpressed in tumor cells, resulting in 
lower cofi  lin activity, displayed signifi  cantly increased survival, 
whereas animals with KS tumors in which the amount of phos-
phorylated cofi  lin is decreased and, therefore, cofi  lin activity is 
increased had dramatically shortened survival. The ability of 
LIMK1 expression to increase survival was not signifi  cantly en-
hanced in animals bearing tumors that were generated from 
cells expressing sixfold more LIMK1 when compared with cells 
expressing threefold more LIMK1 (unpublished data).
Finally, tumor growth was not signifi  cantly affected by al-
tering the expression of F and KS (Fig. 7 B), indicating that the 
changes in metastatic potential and survival resulting from F 
and KS expression were not caused by changes in tumor mass.
LIMK expression is suppressed in tumor 
cells that successfully metastasize 
to the lung
To investigate why some animals with F tumors developed lung 
metastases and died (Figs. 6 and 7), we determined the expres-
sion status of LIMK in lung metastases that were spontaneously 
formed from mammary tumors. Total LIMK1 expression (both 
the endogenous and exogenous genes) in the primary   tumors 
and lung metastases of animals with GFP, F, and KS   tumors was 
examined by real-time PCR (Fig. 8). As shown in Fig. 8, tumor 
cells in lung metastases that formed spontaneously from pri-
mary tumors derived from F cells had lost the   elevated expres-
sion of LIMK and now had wild-type levels of LIMK expression. 
To determine whether elevated LIMK may not be permissive 
Figure 5.  LIMK1 expression inhibits chemotaxis and invasion in vitro and 
in vivo. (A) The invasion of collagen by tumor cells in response to macro-
phages is suppressed in F cells. (B) The ability of carcinoma cells to invade 
microneedles containing matrigel and EGF when placed into primary tu-
mors derived from GFP, F, and KS cells was measured. Tumors derived from 
F cells were reduced in invasion ability, and invasion was rescued by the 
overexpression of coﬁ  lin. Needles that do not contain EGF represent back-
ground. Error bars represent SEM. *, P < 0.05.
Figure 6.  Intravasation and metastasis are determined by the activity of 
coﬁ  lin. (A) The efﬁ  ciency of intravasation measured as the number of tumor 
cells present in circulating blood. (B) The number of lung metastatic tumors 
was reduced in animals with tumors prepared with F cells and increased 
in tumors prepared with KS cells. Error bars represent SEM. *, P < 0.05; 
**, P < 0.01 by Mann-Whitney test.COFILIN REGULATES CANCER CELL INVASION • WANG ET AL. 401
for tumor cell growth in the lung, an experimental metastasis 
method was used in which the GFP, F, or KS cells were injected 
directly into the bloodstream to form lung metastases, thereby 
bypassing invasion and intravasation. In these experimentally 
derived lung metastases, the expression of LIMK remained 
  elevated, as seen in tumors derived from F cells. These results 
indicate that elevated levels of LIMK are not permissive for 
  metastasis to lung but are permissive for the growth of metasta-
ses in the lung.
To determine whether elevated LIMK expression is main-
tained in tumor cells during invasion, the in vivo invasion assay 
was performed in GFP, F, and KS tumors, and the collected 
  tumor cells were subjected to real-time PCR as described in 
Materials and methods. In GFP tumors, the LIMK1 expression 
(along with cofi  lin expression; unpublished data) in the invad-
ing cells is increased compared with all tumor cells of the pri-
mary tumor, as observed previously in invasive cells from 
MTLn3-derived primary tumors (Wang et al., 2004). However, 
in F tumors, although the expression of total LIMK1 in the pri-
mary tumor is high as a result of expression from the exogenous 
LIMK1 gene, the expression of total LIMK1 in the invading 
cells was reduced to levels observed in lung metastases from 
F tumors (Fig. 8). In KS tumors, the expression of total 
LIMK1-related genes (in this case, endogenous LIMK1 plus 
  exogenous KS) was high in the primary tumor, remained ele-
vated in the   invading tumor cells, but was equal to total LIMK 
expression in GFP and F in the lung metastases. These results 
indicate that   elevated levels of LIMK in F tumors are not per-
missive for in  vasion in the primary tumor, whereas elevated KS 
expression is tolerated.
Discussion
As discussed above, previous studies have come to contradic-
tory conclusions as to the role of LIMK1 in tumor cell motility, 
invasion, and metastasis, claiming both increases and decreases 
in cell motility and invasion as a result of LIMK1  overexpression. 
Therefore, it is unlikely that LIMK1 expression alone   directly 
determines the motility, invasion, and metastasis status of carci-
noma cells. LIMK1 is part of the cofi  lin pathway that regulates 
barbed end formation during tumor cell chemotaxis in response 
to EGF (Ghosh et al., 2004; Mouneimne et al., 2004) and is one 
of the genes up-regulated, along with cofi  lin, Rho-associated 
coil-containing protein kinase, and PKCζ, in invasive tumor 
cells during invasion and metastasis (Goswami et al., 2004; 
Wang et al., 2004). These results suggest that it is the overall 
activity of the cofi  lin pathway and not that of LIMK1 alone that 
determines the invasive and metastatic phenotype of tumor 
cells. In this study, we tested this hypothesis by varying the 
  expression of LIMK1 and its dominant-negative kinase domain 
in the rat MTLn3 carcinoma cell line to examine the   effects 
Figure 7.  Overexpression of LIMK1 increases and KS decreases the sur-
vival of animals with mammary tumors. (A) The 50% survival times for ani-
mals bearing GFP and KS tumors are 44 and 32 d, respectively. In the 
case of F (LIMK1), at least 70% of the animals were still alive after 49 d. 
(B) Tumor growth was not affected in tumors prepared from F, KS, and GFP 
cells. Error bars represent SEM.
Figure 8.  Expression of LIMK1 is suppressed in invading and metastatic 
tumor cells but not in tumor cells growing in the lung. Resident total primary 
tumor cells were isolated by FACS-based GFP expression in the cells. Invad-
ing cells were collected with the in vivo invasion assay. Lung metastases 
were isolated from single cell suspensions of lung by FACS based on the 
GFP expression in the tumor cells. RNA was isolated from the aforemen-
tioned cells and analyzed by quantitative real-time PCR for the level of 
LIMK1 mRNA. Invasive tumor cells as well as tumor cells that have sponta-
neously metastasized to the lung from the primary tumor have reduced 
LIMK expression. LIMK levels in tumor cells growing in the lung after intra-
venous injection of tumor cells (experimental metastasis) remained high, in-
dicating that elevated LIMK is permissive for growth in the lung but not 
spontaneous metastasis. Error bars represent SEM.JCB • VOLUME 173 • NUMBER 3 • 2006  402
of LIMK on the activity of the cofi  lin pathway and, conse-
quently, on the invasion and metastasis of primary mammary 
tumors grown from these cells. Our results demonstrate that the 
effect of LIMK1 expression on invasion, intravasation, and 
  metastasis of cancer cells can be most simply explained by the 
regulation and activity status of the cofi  lin  pathway. When 
LIMK1 overexpression (F cells) decreases the activity of the 
cofi  lin pathway (the EGF-induced early barbed end transient), 
the invasion and metastasis of tumor cells is proportionately 
  decreased, whereas if the activity of the cofi  lin pathway is 
  unchanged or increased, as in the GFP and KS cells, the chemo-
taxis, invasion, and metastasis of the tumor cells is either un-
affected or increased. Furthermore, our study indicates that 
the increased expression of LIMK1 in carcinoma cells signi-
fi  cantly reduces their cell motility as the phosphorylation of 
 cofi  lin by LIMK1 abolishes EGF-stimulated actin nucleation, 
protrusion, and chemotaxis in vitro and invasion, intravasation, 
and metastasis in vivo. The in vitro results in particular are 
 consistent with previous studies linking the activity of the  cofi  lin 
pathway to EGF-stimulated directional sensing, protrusion, 
and chemotaxis (Zebda et al., 2000; Ghosh et al., 2004; 
  Mouneimne et al., 2004).
The results reported in this study are consistent with a 
  previous study demonstrating that the expression of the kinase 
domain of LIMK1, which results in the near total phosphoryla-
tion of cofi  lin, inhibits EGF-stimulated actin nucleation, protru-
sion, and motility in tumor cells (Zebda et al., 2000). This 
phenotype is caused by cofi  lin inhibition because these effects 
could be rescued by the expression of S3A cofi  lin, which cannot 
be phosphorylated by LIMK1 (Zebda et al., 2000), whereas the 
similar results reported in this study for F cells could be rescued 
by the overexpression of wild-type cofi  lin. The results reported 
in this study are also consistent with the inhibition of cell motil-
ity by the overexpression of LIMK1 in Ras-transformed Swiss 
3T3   fi  broblasts (Sahai et al., 2001).
It is interesting to note that in cells expressing KS, al-
though barbed ends are slightly elevated, protrusion and inva-
sion in vitro and in vivo are not signifi  cantly affected compared 
with GFP control cells. However, intravasation, metastasis, and 
morbidity are signifi  cantly increased in tumors derived from 
KS cells. This observation is consistent with a recent study 
(Yamaguchi et al., 2005a) showing that cofi  lin affects the as-
sembly and stability of invadopods that are required for 
  intravasation. Furthermore, it is known that tumor cells exhibit 
two different types of cell motility in the primary tumor during 
invasion and intravasation: (1) high velocity amoeboid move-
ment guided by the linear geometry of the extra cellular matrix; 
and (2) slow, directed invadopod-mediated extracellular matrix 
degradation at blood vessels where intravasation occurs (Condeelis 
and   Segall, 2003; Yamaguchi et al., 2005b). Therefore, it is 
  expected that metastasis is the sum of two different types of cell 
motility during invasion and intravasation. Cofi  lin can affect 
both types but may do so unequally. In particular, our results 
indicate that the slightly higher activity of cofi  lin in KS cells 
does not signi  fi  cantly affect protrusion and invasion of amoe-
boid cells but   affects invadopod-dependent intravasation 
(Yamaguchi et al., 2005a). These results suggest that the effect 
of KS on metastatic phenotype is mainly on intravasation, 
which is the rate-limiting step for metastasis (Condeelis and 
Segall, 2003; Wyckoff et al., 2004).
A key feature of the cofi  lin pathway is the generation of 
actin fi  lament barbed ends after stimulation with EGF. Cofi  lin-
generated actin fi  lament barbed ends are required for chemo-
taxis to EGF (Mouneimne et al., 2004), a property essential for 
invasion and metastasis (Condeelis and Segall, 2003; Wyckoff 
et al., 2004). The important role of barbed ends generated by the 
cofi  lin pathway in chemotaxis and invasion makes it essential 
to examine the output of this pathway in cells that have been 
manipulated for the expression of LIMK1. Other studies in 
which the overexpression of LIMK1 in tumor cell lines was 
  reported to increase their motility and invasiveness in vitro 
  (Davila et al., 2003; Yoshioka et al., 2003) might be resolved 
with our studies by measuring cofi  lin-dependent barbed ends 
during chemotaxis to determine whether the activity of the 
 cofi  lin pathway is elevated in their models. Furthermore, the 
stability of LIMK expression in these experimental models 
should be checked to determine whether LIMK1 expression 
was suppressed during invasion and metastasis as observed in 
our study. For example, the inhibitory effect of the overexpres-
sion of LIMK1 on metastasis is emphasized by our observation 
that successful metastatic lung tumors derived from F tumors 
overexpressing LIMK1 have been selected by the tissue micro-
environment for decreased LIMK1 expression independently of 
tumor growth. This observation may explain why our results 
appear inconsistent with previous studies in which the over-
expression of LIMK1 in tumor cells has been reported to increase 
their ability to metastasize to bone in an experimental metasta-
sis model (Yoshioka et al., 2003). To resolve this inconsistency, 
it would be necessary to determine the expression status of 
LIMK1 in the bone metastases.
Other research groups have shown that LIMK1 may play 
a role in regulating cell division in a prostate cancer cell line 
PC3 and mouse embryo fi  broblasts in vitro (Davila et al., 2003; 
Roovers et al., 2003). However, our results demonstrate that 
  tumor growth was not signifi   cantly affected by altering the 
  expression of LIMK1 in F- and KS-derived mammary tumors 
during growth in vivo, indicating that the changes in invasive 
and metastatic potential resulting from F and KS expression 
were not caused by changes in tumor growth and/or mass. The 
different results from our group and others may result from the 
different cell types used in these studies (for example, mam-
mary vs. prostate cancer cells) and differences between growth 
in the local tumor microenvironment in vivo as used in our 
study and growth observed in vitro in the fi  broblast and PC3 
studies (Davila et al., 2003; Roovers et al., 2003).
Microarray analyses of invasive tumor cells collected in 
the in vivo invasion assay indicate that LIMK1 is more highly 
expressed in the most invasive cells compared with the less in-
vasive cells that are residents of the primary tumor (Wang et al., 
2004). This observed increase in LIMK1 expression could lead 
to the incorrect conclusion that the overexpression of LIMK1 
is suffi  cient for increased invasion and metastasis. The most 
  important implication of our study is that looking at the expres-
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collective activity of the pathway of which that gene product is 
a part that determines the metastatic phenotype of a tumor. 
In fact, in the microarray study, the elevated expression of LIMK1 
was coupled with increased levels of the expression of cofi  lin, 
which occurred spontaneously (Wang et al., 2004). In this study, 
the experimental overexpression of both cofi  lin and LIMK is 
required for the activation of the cofi  lin pathway resulting in 
EGF-stimulated protrusion, cell motility, invasion, and metas-
tasis. Our results indicate that in invasive cells collected from 
primary tumors, the stimulatory and inhibitory pathways regu-
lating cofi  lin must be in balance in order for cells to be invasive 
and metastatic. The application of this idea to the analysis of 
microarrays of other pathways may lead to more accurate pre-
dictions of metastatic outcome in breast tumors. Our results 
also suggest that the phosphorylation status of cofi  lin in tumor 
cells within the primary tumor in situ may have value in pre-
dicting the metastatic potential of a breast tumor.
Materials and methods
LIMK constructs, cell culture, transfection, and generation of stable 
expression cell lines
Rat MTLn3 cells were maintained and grown to log phase before being 
used as described previously (Arber et al., 1998; Zebda et al., 2000). 
GFP-F (active GFP-tagged full-length LIMK1), GFP-FS (inactive GFP-tagged 
LIMK1 Short), GFP-K (active GFP-tagged kinase domain of LIMK1), and 
GFP-KS (inactive GFP-tagged kinase domain of LIMK1 Short) were de-
scribed previously (Fig. 2; Arber et al., 1998). Rat nonmuscle coﬁ  lin cDNA 
was subcloned into the EcoRI/BamHI sites of pBabe-Puro, a retroviral vec-
tor with puromycin selection marker (Morgenstern and Land, 1990). To ac-
count for any effects that might arise from the introduction of EGFP into 
cells, MTLn3 cells transfected with pGreenLantern-1 vector (Life Technol-
ogies) were used as controls. The different constructs were introduced into 
cells by transfection using FuGene (Roche). Transfected MTLn3 cells were 
grown in the presence of 500 μg/ml geneticin or 1 μg/ml puromycin 
(Invitrogen) for 3–4 wk to select stable expressers. Cells expressing higher 
amounts of LIMK1 were further selected by increasing the concentration of 
geneticin to 4 mg/ml.
Phospho-coﬁ  lin and immunoblotting
Cells were cultured at low density (30%) and starved free of serum for at 
least 3 h before stimulation with EGF to assure that the cells at time = 0 
were resting. Total cell lysates were resolved in 10% SDS-PAGE and sub-
jected to immunoblotting using goat polyclonal antibody against the 
COOH terminus of LIMK1 (Santa Cruz Biotechnology, Inc.) so that both 
long and short forms of LIMK1 could be detected. Chicken polyclonal anti-
body against rat full-length coﬁ  lin was used for total coﬁ  lin. To measure the 
absolute value of phosphorylated coﬁ  lin, IEF gels (pH 3–10; Bio-Rad Labo-
ratories) were used to separate phospho-coﬁ  lin from coﬁ  lin. Anti–β-actin 
antibody (Sigma-Aldrich) was simultaneously used as an internal control 
for loading. Three separated experiments were performed for all of the 
Western blotting, and statistical analysis was performed with a t test. It 
should be noted that this absolute method is different from the relative 
method used by Zebda et al. (2000) and gave different numerical values.
Imaging and measurements of free barbed ends and motility
All pictures were taken of live cultures at 37°C and of all cells using a 60× 
NA 1.4 inﬁ   nity-corrected objective on a microscope (IX170; Olympus) 
supplemented with a computer-driven cooled CCD camera (SensiCam QE; 
Cooke) operated by IPLab Spectrum software (VayTek). Digital images 
were linearly converted in ImageJ software (National Institutes of Health 
[NIH]) and analyzed using macro analysis.
Cell culture and barbed end assay. MTLn3 cells were maintained 
and cultured for the light microscopy experiments and quantization of free 
barbed ends as previously described (Mouneimne et al., 2004).
Membrane protrusion assay. MTLn3 cells were starved for 3 h, stim-
ulated with 5 nM EGF at 37°C, and time-lapse series were recorded for up 
to 10 min after the addition of EGF. Area fold change was quantitated by 
tracing cells and measuring their area in ImageJ at 1-min intervals after the 
EGF addition. Area measurements of each cell were standardized over the 
area of the corresponding cell at time = 0 and were averaged and plotted 
versus time after EGF addition.
Average velocity analysis. Time-lapse series of 60 min (one frame 
per minute) were recorded for MTLn3 cells maintained in serum-supplied 
media. Cells were traced throughout all of the frames. Velocities from 
frame to frame were measured in Dynamic Image Analysis System (DIAS) 
for at least 20 cells pooled from three independent experiments.
GFP RNAi transfection. GFP siRNA was purchased from QIAGEN, 
and transfection was performed as previously described (Mouneimne 
et al., 2004). The siRNA knockdown efﬁ  ciency was determined by measur-
ing the ﬂ  uorescence of the residual GFP.
In vitro invasion assay
The in vitro invasion assay measures the ability of macrophages to induce 
the invasion of a dense collagen gel by tumor cells, mimicking a para-
crine-induced invasion as observed in primary mammary tumors (Wyckoff 
et al. 2004). This assay was performed as described previously (Goswami 
et al., 2005). In brief, MTLn3-GFP (n = 80,000) were plated on a 35-mm 
dish ( 80 cells/mm
2; MatTek) in the presence or absence of 200,000 
BAC1.2F5 cells in 2 ml α-MEM with 10% FBS and 36 ng/ml CSF-1. After 
16 h, cells were overlaid with a 750–1,000-μm layer of 5–6 mg/ml col-
lagen I, which was allowed to gel for 90 min before the addition of 1 ml 
α-MEM with 10% chemically deﬁ   ned lipid mix (Invitrogen) and insulin-
transferrin-selenium (Invitrogen). After 24 h, the assay was ﬁ  xed with 4% 
formaldehyde and analyzed by confocal microscopy; optical z sections 
were taken every 5 μm starting at the base of the dish and extending at 
least 50 μm into the collagen gel. To quantify the invasion of MTLn3-GFP 
cells, GFP ﬂ  uorescence in the z sections from 20 μm into the collagen and 
above was added and divided by the sum of GFP ﬂ  uorescence in all of the 
z sections. The data shown represent the analysis of ≥200 cells with data 
collected from at least three independent experiments.
In vivo invasion assay
We used MTLn3-derived mammary tumors in rats and the in vivo invasion 
assay described previously (Wyckoff et al., 2004) to study cancer cell 
  invasion. In brief, the in vivo invasion assay uses microneedles ﬁ  lled with 
matrigel and growth factors (EGF in this case) to collect the invasive tumor 
cells from primary tumors. Microneedles are held in a clamping devise 
and positioned in the primary tumor with a micromanipulator. Cell collec-
tion takes 2.5–4 h, and the number of tumor cells collected was counted 
as described previously (Wyckoff et al., 2004). For barbed end staining, 
the needle-collected invasive tumor cells and total resident tumor cells 
  collected from the primary tumor by FACS sorting of GFP were plated on 
collagen-coated dishes (MatTek) for  12 h and were starved for 4 h be-
fore EGF stimulation. Control experiments include the exposure of FACS-
sorted tumor cells to EGF to mimic the collection conditions used for 
invasive cells (Wang et al., 2004).
Blood burden, tumor cells in the lung, and metastases
MTLn3 cells were injected into the mammary fat pads of female Fischer 
344 rats to form primary tumors. After tumor growth, tumor cell blood bur-
den was determined as described previously (Wang et al., 2004). For the 
measurement of spontaneous metastases, after blood removal and euthani-
zation of the rat, the lungs were removed, and the visible metastatic tumors 
near the surface of the lungs were counted as described previously (Wang 
et al., 2004). In a separate experiment, animals bearing MTLn3-LIMK1 (F), 
MTLn3-KS (KS), or MTLn3-GFP (GFP) tumors were used to observe the effect 
of LIMK1 on animal survival. At least nine animals were used in each 
group. The animals were dissected after the animal died, and the metasta-
ses were scored by checking the visible metastatic tumors on the lung 
  surface. After 7 wk, all of the animals were killed and dissected to check 
the metastases.
To study experimental lung metastasis, 7.5 × 10
5 cells were injected 
into the lateral tail veins of 7-wk-old female rats. 2.5 wk after injection, the 
rats were killed, and the lungs were removed for isolation of carcinoma 
cells using the method described below.
Real-time PCR
To check the expression level of LIMK1 in the resident tumor and lung 
  meta  stases, quantitative real-time PCR analysis was performed by using a 
sequence detection system (ABI PRISM 7900; Applied Biosystems) with 
  sequence-speciﬁ  c primer pairs for LIMK1 as described previously (Wang 
et al., 2004). To isolate the carcinoma cells from primary tumor or lung, a 
small piece of tumor or lung tissue was minced and ﬁ  ltered twice through JCB • VOLUME 173 • NUMBER 3 • 2006  404
a nylon ﬁ  lter to obtain a single cell suspension. FACS was performed on 
the resulting single cell suspensions based on their GFP expression in tumor 
cells using a cell sorter (FACSVantage; Becton Dickinson). SYBR Green was 
used for real-time monitoring of ampliﬁ  cation. Results were evaluated with 
ABI PRISM SDS 2.0 software (Applied Biosystems). The normalization of all 
samples was performed using at least two housekeeping genes (β-actin 
and glyceraldehyde-3-phosphate dehydrogenase).
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